BioRegenx, Inc.

10-Q Quarter ended 2026-03-31 May 20, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Director or officer change Apr 14, 2025 8-K Director or officer change Jan 22, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Director or officer change Oct 11, 2024 10-Q Quarter ended 2024-06-30 Oct 9, 2024 10-Q/A Quarter ended 2024-03-31 Oct 9, 2024 8-K/A Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Amended charter or bylaws Oct 9, 2024 8-K Director or officer change Jul 23, 2024 8-K Director or officer change Jul 15, 2024 8-K Changed accountants; Previously issued financials not reliable Jun 11, 2024 10-Q/A Quarter ended 2024-03-31 May 29, 2024 10-Q Quarter ended 2024-03-31 May 24, 2024 8-K Changed accountants May 16, 2024 10-K Fiscal year ended 2023-12-31 Apr 12, 2024 8-K Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Amended charter or bylaws Apr 1, 2024 10-Q Quarter ended 2023-09-30 Nov 20, 2023 10-Q Quarter ended 2023-06-30 Aug 15, 2023 10-Q Quarter ended 2023-03-31 May 22, 2023 10-K Fiscal year ended 2022-12-31 Apr 4, 2023 8-K Entered a material agreement Jan 6, 2023 10-Q Quarter ended 2022-09-30 Nov 21, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 10-Q Quarter ended 2022-03-31 May 23, 2022 10-K Fiscal year ended 2021-12-31 Apr 13, 2022 10-Q Quarter ended 2021-09-30 Nov 22, 2021 NT 10-Q EXTENSION May 15, 2026 NT 10-K EXTENSION Apr 1, 2026 NT 10-K Apr 1, 2025 3 Jan 2, 2025 NT 10-Q EXTENSION Aug 12, 2024 CORRESP Jul 22, 2024 SC 13D/A AMENDMENT TO SCHEDULE 13D Jul 22, 2024 CORRESP Jul 19, 2024